Peter Thiel-backed psychedelic start-up’s shares pop in Wall Street debut
The German biotech’s initial public offering was priced Thursday night at $15 per share, the high end of the expected range.
—————
TRANSCOM ISP – Free Sigma HSE Email
Level 6 Domain Names are FREE – Register Now.